Gene · 3691
Papers3,577
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,577
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-aging effect of low molecular weight recombinant humanized collagen on photo-aging by activating adherence junction signaling pathways. | PLoS One | 2025 | 40880343 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in Mediating Signaling in Biliary Epithelial Cell Activation and Cholangiopathies. | Cells | 2025 | 40862753 | PubTator, text mining | PubMed |
| Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical-Laboratory Experience of a Single Central European Reference Centre. | Antibodies (Basel) | 2025 | 40843678 | PubTator, text mining | PubMed |
| Opposing mechanisms by which miRNAs mediate distinct Nrf1 and Nrf2 regulation of epithelial-mesenchymal transition in hepatocellular carcinoma. | RNA Biol | 2025 | 40836845 | PubTator, text mining | PubMed |
| PD-L1/ITGB4 Axis Modulates Sensitivity of Hepatocellular Carcinoma to Sorafenib via FAK/AKT/mTOR Signaling Pathway. | Immunotargets Ther | 2025 | 40827229 | PubTator, text mining | PubMed |
| Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. | Eur J Med Res | 2025 | 40826140 | PubTator, text mining | PubMed |
| USP44 Regulates Chemoresistance Induced by ROS and the MAPK/NF-κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer. | FASEB J | 2025 | 40824171 | PubTator, text mining | PubMed |
| High expression of LIMD2 predicts a poor prognosis and promotes migration of colon cancer cells. | Discov Oncol | 2025 | 40813949 | PubTator, text mining | PubMed |
| Junctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion. | Int J Mol Sci | 2025 | 40806473 | PubTator, text mining | PubMed |
| Neddylation inhibitor MLN4924 enhances H3K18 lactylation via binding to LDH and downregulates ITGB4 to block metastasis. | J Biol Chem | 2025 | 40784455 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Potential of Salivary Exosomes in Corneal Epithelial Wound Healing. | Invest Ophthalmol Vis Sci | 2025 | 40762539 | PubTator, text mining | PubMed |
| Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies. | J Hematol Oncol | 2025 | 40750884 | PubTator, text mining | PubMed |
| Systematic analysis of ZDHHC9 as a potential prognostic and immunotherapy biomarker in breast cancer. | Front Immunol | 2025 | 40740766 | PubTator, text mining | PubMed |
| Attachment of Human Epithelial Cells to an Anodized Titanium Surface. | Materials (Basel) | 2025 | 40731515 | PubTator, text mining | PubMed |
| Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC. | Breast Cancer Res | 2025 | 40731028 | PubTator, text mining | PubMed |
| Mechanobiological engineering strategies for organoid culture. | APL Bioeng | 2025 | 40688244 | PubTator, text mining | PubMed |
| Identification of AKOS, a Chikungunya virus inhibitor, as a USP14 inhibitor for colorectal cancer treatment. | Acta Pharmacol Sin | 2025 | 40676218 | PubTator, text mining | PubMed |
| ncRNA-mediated ITGB1 upregulation correlates with poor prognosis and tumor-immune infiltration in gastric cancer. | Eur J Med Res | 2025 | 40660403 | PubTator, text mining | PubMed |
| Titanium surface modified with nanostructure mimicking the surface of natural cementum up-regulated epithelial expression of integrin β4 and enhanced the attachment of the transmucosal gingiva. | Dent Mater | 2025 | 40628621 | PubTator, text mining | PubMed |
| Prognostic analysis and mechanistic exploration of the autophagy-related exosome genes ITGA3, ITGB4, and PTK6 in pancreatic ductal adenocarcinoma. | Discov Oncol | 2025 | 40591082 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3691/papers?page=5